Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

12 Of Japan’s 13 Drug Makers Expect Higher Profits This Year

This article was originally published in PharmAsia News

Executive Summary

All but one of Japan's 13 pharmaceutical companies are expected to see increased profits this year, according to national survey of drug makers. Only Astellas Pharma is expected to end the year lower than the year before. The survey of companies indicates they have been relatively immune to recent economic downturns. Another factor is seen in the government's schedule for reviewing drug prices, now not scheduled before April of next year. Drug makers Hisamitsu Pharmaceutical and Tsumura are expected to post double-digit profit increases this year. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071000

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel